Should all breast cancers be diagnosed by needle biopsy? - 18/08/11
, Teresa Ponn, M.D. a, Liva Andrejeva, M.D. b, Liane Philpotts, M.D. b
Corresponding author. Tel.: +1-203-785-2328; fax: +1-203-785-2329.Abstract |
Background |
Although much data support the National Quality Forum recommendation that breast cancers should be diagnosed by needle biopsy before surgical resection, the exclusion criteria for those that may not be suitable have yet to be defined.
Methods |
We reviewed all patients treated over the past 3 years at the Yale Breast Center to determine the percentage of patients not diagnosed by needle biopsy, and why.
Results |
Reasons for the 17% of 630 patients who were not diagnosed by needle biopsy were as follows: inability to cooperate (1%); small or superficial lesion less than 1 cm that technically was easier to excise in the office (4%); bloody discharge without clinical or mammographic mass (1%); lesion adjacent to implant (.5%); a mammographic lesion that was too posterior, too superficial, or too faint to be performed stereotactically (5%); or patient preference (5%).
Conclusions |
Needle biopsy is the preferred method of diagnosis in most cases, but there are valid reasons why all breast cancers will not be diagnosed in this fashion.
El texto completo de este artículo está disponible en PDF.Keywords : Breast cancer diagnosis, Needle biopsy
Esquema
Vol 192 - N° 4
P. 450-454 - octobre 2006 Regresar al número
Artículo precedente
- Digital documentation of the physical examination: moving the clinical breast exam to the electronic medical record
- Cary S. Kaufman, Leslie Jacobson, Barbara A. Bachman, Lauren B. Kaufman
- What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?
- Helen Mabry, Armando E. Giuliano, Melvin J. Silverstein
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?